| Literature DB >> 34747731 |
Arvind Kumar1, C Vijay Lingaraju2, Mohan Venkatesh Pulle1, Belal Bin Asaf1, Harsh Vardhan Puri1, Sukhram Bishnoi1.
Abstract
BACKGROUND: Few studies have compared the surgical outcomes between tubercular empyema (TE) and nontubercular empyema (NTE), which were limited by a small sample size. We conducted this study with the objective of comparing the surgical outcomes of patients with tuberculous and nontuberculous empyema.Entities:
Keywords: Empyema; nontubercular; surgical outcomes; tubercular
Year: 2021 PMID: 34747731 PMCID: PMC8614609 DOI: 10.4103/lungindia.lungindia_33_21
Source DB: PubMed Journal: Lung India ISSN: 0970-2113
Nontubercular empyema: Causes (n=119)
| Cause | Number of cases |
|---|---|
| Postpneumonic | 72 |
| CKD-associated empyema | 20 |
| Posttraumatic | 8 |
| Recurrent empyema | 6 |
| Postpneumothorax | 4 |
| Postesophageal perforation | 2 |
| Post-PCNL | 2 |
| Rheumatoid arthritis effusion | 2 |
| Subphrenic abscess | 1 |
| Postpancreatitis | 2 |
CKD: Chronic kidney disease, PCNL: Percutaneous nephrolithotomy
Figure 1Institutional protocol of management of empyema thoracis
Demographic details tubercular versus nontubercular empyema
| Characteristics | TE, | NTE, |
|
|---|---|---|---|
| Number of patients | 166 | 119 | - |
| Male:female | 123:43 (74.1: 25.9) | 91:28 (76.5: 23.5) | 0.68 |
| Age (years) | 31.2±13.6 | 45.4±17.2 | <0.001 |
| Body mass index (kg/m2) | 21.4±2.8 | 24.2±3.1 | <0.001 |
| Number of comorbidities | |||
| No comorbidity | 133 (80.1) | 57 (48) | <0.001 |
| 1 comorbidity | 23 (13.9) | 31 (26) | 0.01 |
| ≥2 comorbidity | 10 (6) | 31 (26) | <0.001 |
| Comorbidities | |||
| Hypertension | 14 (8.4) | 52 (43) | |
| Diabetes mellitus | 11 (6.6) | 43 (36) | |
| Coronary artery disease | 9 (5.4) | 20 (16.8) | |
| CKD | 10 (6) | 20 (16.8) | |
| COPD | 8 (4.8) | 9 (7.5) | |
| Rheumatoid arthritis | 1 (0.6) | 0 | |
| Symptoms | |||
| Fever | 102 (61.4) | 102 (85.7) | |
| Cough | 63 (37.9) | 56 (47) | |
| Chest pain | 51 (30.7) | 90 (75.6) | |
| Dyspnea on exertion | 30 (18) | 109 (91.5) | |
| Mean duration of symptoms (months) | 5.2±4.8 | 2.1±1.9 | <0.001 |
| Side of disease | |||
| Right | 89 (53. 6) | 62 (52.1) | - |
| Left | 75 (45.2) | 52 (43.6) | |
| Bilateral | 2 (1.2) | 5 (4.3) | |
| Preoperative interventions | |||
| Needle aspiration | 149 (89.7) | 92 (77.3) | 0.005 |
| Multiple (≥2) aspirations | 38 (22.9) | 36 (30.2) | 0.17 |
| ICD placement | 85 (51.2) | 34 (28.5) | 0.005 |
TE: Tubercular empyema, NTE: Nontubercular empyema, COPD: Chronic obstructive pulmonary disease, CKD: Chronic kidney disease, ICD: Intercostal drain
Comparison of intraoperative variables between tubercular empyema and nontubercular empyema group
| Characteristics | TE ( | NTE ( |
|
|---|---|---|---|
| Method of surgery | |||
| Started by VATS | 123 (74.1) | 70 (58.8) | 0.007 |
| Successful | 112/123 (91.1) | 54/70 (77.2) | 0.01 |
| Converted to thoracotomy | 11/123 (8.9) | 16/70 (22.8) | <0.001 |
| Started by thoracotomy | 43 (25.9) | 49 (41.2) | 0.39 |
| Surgery | |||
| Decortication only | 157 (94.5) | 109 (91.5) | |
| Decortication wedge or lobectomy | 6 (3.6) | 7 (5.8) | |
| Window thoracostomy | 3 (1.8) | 3 (2.5) | |
| Operative time (min) | 218±38.4 | 248.4±62.8 | <0.001 |
| Intra operative blood loss (ml) | 288.7±37.3 | 301.7±42.3 | 0.006 |
TE: Tubercular empyema, NTE: Nontubercular empyema, VATS: Videoassisted thoracoscopic surgery
Comparison of postoperative variables between tubercular empyema and nontubercular empyema group
| TE ( | NTE ( |
| |
|---|---|---|---|
| Need for postoperative ventilation | 2 (1.2) | 12 (10.08) | 0.001 |
| Need for postoperative ICU stay | 5 (3) | 30 (25.2) | <0.001 |
| Prolonged air leak (>7 days) | 35 (21) | 25 (21) | 0.76 |
| Postoperative ICD duration (days) | 7.4±2.3 | 7.9±3.1 | 0.12 |
| Hospital stay (days) | 7.1±3.2 | 9.7±3.0 | <0.001 |
| Mean time to return to full work (days) | 24.5±3.8 | 32.8±5.9 | <0.001 |
TE: Tubercular empyema, NTE: Nontubercular empyema, ICU: Intensive care unit, ICD: Intercostal drain
Comparison of complications and mortality between tubercular empyema and nontubercular empyema group
| TE ( | NTE ( |
| |
|---|---|---|---|
| Number of complications (overall) | 9 (5.4) | 16 (13.4) | 0.02 |
| Bleeding | 0 | 2 (1.6) | 0.17 |
| Wound infection | 4 (2.4) | 9 (7.5) | 0.04 |
| Atelectasis and pneumonia | 2 (1.2) | 3 (2.5) | 0.65 |
| Cardiac arrhythmias | 1 (0.6) | 0 | 1.0 |
| Renal complications | 2 (1.2) | 2 (1.6) | 1.0 |
| Recurrence | 5 (3.01) | 5 (4.2) | 0.33 |
| Perioperative mortality (<30 days) | 0 | 12 (10) | <0.001 |
TE: Tubercular empyema, NTE: Nontubercular empyema
Predictors of perioperative mortality
| Variables | Characteristics | Mortality |
|
|---|---|---|---|
| Age (years) | ≤40 ( | 0 | 0.03 |
| >40 ( | 12 | ||
| Comorbidities | Present ( | 12 | 0.03 |
| Absent ( | 0 | ||
| Duration of symptoms (months) | <2 ( | 6 | 0.18 |
| ≥2 ( | 6 | ||
| Method of surgery | VATS ( | 3 | 0.02 |
| Open ( | 9 | ||
| Culture positivity | Yes ( | 7 | 0.21 |
| No ( | 5 |
VATS: Video-assisted thoracoscopic surgery